Literature DB >> 17492605

Isoniazid activity is terminated by bacterial persistence.

Denis A Mitchison, Amina Jindani, Geraint R Davies, Frederik Sirgel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17492605     DOI： 10.1086/518046

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  11 in total

Review 1.  An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors:  Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

2.  Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.

Authors:  Kerstin A Wolff; Hoa T Nguyen; Richard H Cartabuke; Ajay Singh; Sam Ogwang; Liem Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

Review 3.  A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs.

Authors:  Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Curr Opin Pharmacol       Date:  2011-07-30       Impact factor: 5.547

Review 4.  The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.

Authors:  Véronique Dartois
Journal:  Nat Rev Microbiol       Date:  2014-02-03       Impact factor: 60.633

5.  Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling.

Authors:  Shashikant Srivastava; Carleton Sherman; Claudia Meek; Richard Leff; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2011-09-06       Impact factor: 5.191

6.  The DosR regulon of M. tuberculosis and antibacterial tolerance.

Authors:  I L Bartek; R Rutherford; V Gruppo; R A Morton; R P Morris; M R Klein; K C Visconti; G J Ryan; G K Schoolnik; A Lenaerts; M I Voskuil
Journal:  Tuberculosis (Edinb)       Date:  2009-07-03       Impact factor: 3.131

7.  Diverse drug-resistant subpopulations of Mycobacterium tuberculosis are sustained in continuous culture.

Authors:  Diepreye Ayabina; Charlotte Hendon-Dunn; Joanna Bacon; Caroline Colijn
Journal:  J R Soc Interface       Date:  2016-11       Impact factor: 4.118

8.  Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315.

Authors:  Rose E Jeeves; Alice A N Marriott; Steven T Pullan; Kim A Hatch; Jon C Allnutt; Irene Freire-Martin; Charlotte L Hendon-Dunn; Robert Watson; Adam A Witney; Richard H Tyler; Catherine Arnold; Philip D Marsh; Timothy D McHugh; Joanna Bacon
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

Review 9.  Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.

Authors:  Liesbeth Mieras; Richard Anthony; Wim van Brakel; Martin W Bratschi; Jacques van den Broek; Emmanuelle Cambau; Arielle Cavaliero; Christa Kasang; Geethal Perera; Lee Reichman; Jan Hendrik Richardus; Paul Saunderson; Peter Steinmann; Wing Wai Yew
Journal:  Infect Dis Poverty       Date:  2016-06-08       Impact factor: 4.520

10.  Isoniazid Killing of Mycobacterium smegmatis NADH Pyrophosphatase Mutant at Single-Cell Level using Microfluidics and Time-Lapse Microscopy.

Authors:  Meltem Elitas
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.